Discovery Laboratories has hired former AstraZeneca Senior Medical Director Steve Simonson as VP, Clinical Development and former PARI VP and Director of Product Technology Lawrence Weinstein as VP, Medical Device Development, the company said. The new hires, both of whom have extensive OINDP experience, will oversee development of the Aerosurf aerosolized KL4 surfactant product, which is currently in Phase 2.
Discovery Labs’ Senior VP, Research and Development Russell Clayton commented, “Though the initial focus of both Steve and Larry will be on Aerosurf and premature infants born at risk for respiratory distress syndrome, our KL4 surfactant and drug delivery technology has the potential to address a significant number of additional diseases where surfactant deficiency is a problem. I believe that Steve and Larry will provide additional depth and scientific rigor to the excellent work already underway at Discovery. Their extensive experience in pulmonary medicine, neonatal drug development, and medical device development including capillary-based aerosolization technology will apply immediately to the Aerosurf program, and more broadly as we develop our respiratory critical care franchise.”
Read the Discovery Labs press release.
